Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ekso Bionics Holdings (EKSO) EBT Margin (2016 - 2025)

Historic EBT Margin for Ekso Bionics Holdings (EKSO) over the last 13 years, with Q3 2025 value amounting to 33.59%.

  • Ekso Bionics Holdings' EBT Margin rose 322300.0% to 33.59% in Q3 2025 from the same period last year, while for Sep 2025 it was 76.35%, marking a year-over-year decrease of 87400.0%. This contributed to the annual value of 59.85% for FY2024, which is 244700.0% up from last year.
  • According to the latest figures from Q3 2025, Ekso Bionics Holdings' EBT Margin is 33.59%, which was up 322300.0% from 196.4% recorded in Q2 2025.
  • Over the past 5 years, Ekso Bionics Holdings' EBT Margin peaked at 33.59% during Q3 2025, and registered a low of 196.4% during Q2 2025.
  • For the 5-year period, Ekso Bionics Holdings' EBT Margin averaged around 102.47%, with its median value being 97.87% (2022).
  • Per our database at Business Quant, Ekso Bionics Holdings' EBT Margin surged by 1635200bps in 2021 and then crashed by -1477400bps in 2025.
  • Quarter analysis of 5 years shows Ekso Bionics Holdings' EBT Margin stood at 112.56% in 2021, then decreased by -13bps to 126.78% in 2022, then surged by 43bps to 72.52% in 2023, then skyrocketed by 38bps to 44.97% in 2024, then increased by 25bps to 33.59% in 2025.
  • Its EBT Margin stands at 33.59% for Q3 2025, versus 196.4% for Q2 2025 and 104.06% for Q1 2025.